Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$2.51B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.53B |
| 3 |
Amazon
AMZN
|
+$1.11B |
| 4 |
Airbnb
ABNB
|
+$574M |
| 5 |
NVIDIA
NVDA
|
+$519M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$588M |
| 2 |
NIO
NIO
|
+$539M |
| 3 |
Apple
AAPL
|
+$525M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$443M |
| 5 |
Microsoft
MSFT
|
+$375M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 90.77% |
| 2 | Consumer Discretionary | 1.94% |
| 3 | Technology | 1.9% |
| 4 | Communication Services | 1.42% |
| 5 | Financials | 1.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4701
Vicor
VICR
$8.66B
| $3.37M | ﹤0.01% |
31,867
+4,385
| +16% | +$390K |
|
4702
CALL
CVR Partners
UAN
$1.32B
| $3.37M | ﹤0.01% |
54,400
-69,000
| -56% | -$3.87M |
|
|
BPMC
4703
DELISTED
Blueprint Medicines
BPMC
| $3.37M | ﹤0.01% |
38,275
+27,466
| +254% | +$2.52M |
|
4704
PUT
Prothena Corp
PRTA
$479M
| $3.36M | ﹤0.01% |
65,400
+30,600
| +88% | +$955K |
|
|
WCC
4705
WESCO International
WCC
$16.4B
| $3.36M | ﹤0.01% |
32,694
+11,339
| +53% | +$1.13M |
|
4706
PUT
Kaiser Aluminum
KALU
$2.56B
| $3.36M | ﹤0.01% |
27,200
+22,700
| +504% | +$2.83M |
|
|
AZPN
4707
PUT
DELISTED
ASPEN TECHNOLOGY INC
AZPN
| $3.36M | ﹤0.01% |
24,400
-4,400
| -15% | -$605K |
|
4708
PUT
Eagle Materials
EXP
$6.06B
| $3.35M | ﹤0.01% |
23,600
-700
| -3% | -$101K |
|
4709
CALL
8x8 Inc
EGHT
$287M
| $3.35M | ﹤0.01% |
120,800
-15,700
| -12% | -$445K |
|
4710
Emergent Biosolutions
EBS
$303M
| $3.35M | ﹤0.01% |
53,172
+4,063
| +8% | +$261K |
|
|
NOAH
4711
Noah Holdings
NOAH
$589M
| $3.35M | ﹤0.01% |
70,953
+44,618
| +169% | +$1.97M |
|
|
HAAC
4712
DELISTED
Health Assurance Acquisition Corp. Class A Common Stock
HAAC
| $3.35M | ﹤0.01% |
334,122
+309,141
| +1,238% | +$3.15M |
|
4713
Commercial Metals
CMC
$7.48B
| $3.34M | ﹤0.01% |
108,862
+47,418
| +77% | +$1.47M |
|
4714
CALL
Amplify Cybersecurity ETF
HACK
$2.97B
| $3.34M | ﹤0.01% |
54,400
-42,700
| -44% | -$2.48M |
|
4715
PUT
Galicia Financial Group
GGAL
$6.78B
| $3.34M | ﹤0.01% |
387,600
+123,300
| +47% | +$1.04M |
|
4716
PUT
NETGEAR
NTGR
$573M
| $3.34M | ﹤0.01% |
87,200
+38,700
| +80% | +$1.5M |
|
|
STMP
4717
DELISTED
Stamps.com, Inc.
STMP
| $3.34M | ﹤0.01% |
16,677
-55,004
| -77% | -$10.8M |
|
|
VNET
4718
VNET Group
VNET
$1.86B
| $3.34M | ﹤0.01% |
145,511
+51,661
| +55% | +$1.32M |
|
4719
iShares Russell 3000 ETF
IWV
$20.3B
| $3.34M | ﹤0.01% |
13,034
+7,181
| +123% | +$1.79M |
|
4720
Karyopharm Therapeutics
KPTI
$42.4M
| $3.33M | ﹤0.01% |
21,540
+1,176
| +6% | +$171K |
|
|
ARNA
4721
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $3.33M | ﹤0.01% |
48,895
-35,864
| -42% | -$2.34M |
|
4722
Ingersoll Rand
IR
$30.5B
| $3.33M | ﹤0.01% |
68,211
+18,863
| +38% | +$926K |
|
4723
Zai Lab
ZLAB
$2.93B
| $3.33M | ﹤0.01% |
18,807
-1,456
| -7% | -$234K |
|
|
KRTX
4724
CALL
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $3.33M | ﹤0.01% |
29,200
+11,700
| +67% | +$1.37M |
|
4725
Vanguard Ultra-Short Bond ETF
VUSB
$9.34B
| $3.33M | ﹤0.01% |
+66,350
| New | +$3.32M |
|
Similar funds
Jeff Yass's Q2 2021 Portfolio in Review
As of Q2 2021, Jeff Yass held 13,792 positions worth $712B, up 12% from $634B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Jeff Yass's Q2 2021 filing shows 1,607 new, 5,174 increased, 5,388 reduced and 1,330 closed positions. Its largest new stake was PRA Health Sciences, Inc.: 622,837 shares worth $103M. The largest sale was iShares iBoxx $ Investment Grade Corporate Bond ETF, an estimated $588M.
By sector, the portfolio is most concentrated in Miscellaneous at 91% of assets, down from 91% a quarter earlier, followed by Consumer Discretionary and Technology.
- Jeff Yass's largest Q2 2021 buy was PRA Health Sciences, Inc.: 622,837 shares worth $103M.
- Jeff Yass added most to Walt Disney in Q2 2021, an estimated $2.51B increase.
- Jeff Yass's biggest Q2 2021 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $588M.
- Jeff Yass fully exited iShares Core MSCI EAFE ETF in Q2 2021, selling an estimated $59.3M.
- Jeff Yass's ten largest holdings make up 30% of its $712B portfolio in Q2 2021.
- Jeff Yass opened 1,607 new positions and closed 1,330 in Q2 2021.
- Jeff Yass's portfolio value rose 12% quarter-over-quarter to $712B.
Based on Susquehanna International Group's 13F filing for Q2 2021, filed 11 Aug 2021.